EdgarLookup

NATIONAL HEALTHCARE CORP — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NATIONAL HEALTHCARE CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $382.66M Nov 6, 2025
Q2 2025 Jun 30, 2025 $374.91M Aug 7, 2025
Q1 2025 Mar 31, 2025 $373.70M May 8, 2025
Q3 2025 Sep 30, 2024 $340.20M Nov 6, 2025
Q2 2025 Jun 30, 2024 $300.66M Aug 7, 2025
Q1 2025 Mar 31, 2024 $297.18M May 8, 2025
Q3 2024 Sep 30, 2023 $288.49M Nov 7, 2024
Q2 2024 Jun 30, 2023 $282.58M Aug 8, 2024
Q1 2024 Mar 31, 2023 $269.56M May 9, 2024
Q3 2023 Sep 30, 2022 $270.84M Nov 2, 2023
Q2 2023 Jun 30, 2022 $271.36M Aug 3, 2023
Q1 2023 Mar 31, 2022 $278.98M May 4, 2023
Q3 2022 Sep 30, 2021 $276.74M Nov 3, 2022
Q2 2022 Jun 30, 2021 $263.16M Aug 4, 2022
Q1 2022 Mar 31, 2021 $250.97M May 5, 2022
Q3 2021 Sep 30, 2020 $250.63M Nov 4, 2021
Q2 2021 Jun 30, 2020 $261.64M Aug 5, 2021
Q1 2021 Mar 31, 2020 $256.12M May 6, 2021
Q3 2020 Sep 30, 2019 $247.07M Nov 5, 2020
Q2 2020 Jun 30, 2019 $247.15M Aug 7, 2020

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $39.24M Nov 6, 2025
Q2 2025 Jun 30, 2025 $23.72M Aug 7, 2025
Q1 2025 Mar 31, 2025 $32.21M May 8, 2025
Q3 2025 Sep 30, 2024 $42.79M Nov 6, 2025
Q2 2025 Jun 30, 2024 $26.84M Aug 7, 2025
Q1 2025 Mar 31, 2024 $26.21M May 8, 2025
Q3 2024 Sep 30, 2023 $10.39M Nov 7, 2024
Q2 2024 Jun 30, 2023 $16.28M Aug 8, 2024
Q1 2024 Mar 31, 2023 $11.72M May 9, 2024
Q3 2023 Sep 30, 2022 ($2.43M) Nov 2, 2023
Q2 2023 Jun 30, 2022 $3.20M Aug 3, 2023
Q1 2023 Mar 31, 2022 $15.32M May 4, 2023
Q3 2022 Sep 30, 2021 ($3.35M) Nov 3, 2022
Q2 2022 Jun 30, 2021 $104.88M Aug 4, 2022
Q1 2022 Mar 31, 2021 $21.27M May 5, 2022
Q3 2021 Sep 30, 2020 $12.85M Nov 4, 2021
Q2 2021 Jun 30, 2020 $28.32M Aug 5, 2021
Q1 2021 Mar 31, 2020 ($26.85M) May 6, 2021
Q3 2020 Sep 30, 2019 $19.46M Nov 5, 2020
Q3 2019 Jun 30, 2019 $13.71M Nov 5, 2019

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $30.38M Nov 6, 2025
Q2 2025 Jun 30, 2025 $34.09M Aug 7, 2025
Q1 2025 Mar 31, 2025 $30.77M May 8, 2025
Q3 2025 Sep 30, 2024 $22.79M Nov 6, 2025
Q2 2025 Jun 30, 2024 $22.52M Aug 7, 2025
Q1 2025 Mar 31, 2024 $15.68M May 8, 2025
Q3 2024 Sep 30, 2023 $13.03M Nov 7, 2024
Q2 2024 Jun 30, 2023 $13.98M Aug 8, 2024
Q1 2024 Mar 31, 2023 $10.01M May 9, 2024
Q3 2023 Sep 30, 2022 $4.08M Nov 2, 2023
Q2 2023 Jun 30, 2022 $4.55M Aug 3, 2023
Q1 2023 Mar 31, 2022 $14.22M May 4, 2023
Q3 2022 Sep 30, 2021 $12.76M Nov 3, 2022
Q2 2022 Jun 30, 2021 $13.80M Aug 4, 2022
Q1 2022 Mar 31, 2021 $15.22M May 5, 2022
Q3 2021 Sep 30, 2020 $7.02M Nov 4, 2021
Q2 2021 Jun 30, 2020 $12.55M Aug 5, 2021
Q1 2021 Mar 31, 2020 $15.81M May 6, 2021
Q3 2020 Sep 30, 2019 $6.57M Nov 5, 2020
Q2 2020 Jun 30, 2019 $10.19M Aug 7, 2020